142 related articles for article (PubMed ID: 18316554)
1. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
[TBL] [Abstract][Full Text] [Related]
2. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
Leman ES; Schoen RE; Weissfeld JL; Cannon GW; Sokoll LJ; Chan DW; Getzenberg RH
Cancer Res; 2007 Jun; 67(12):5600-5. PubMed ID: 17575123
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
4. Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation.
Xue G; Wang X; Yang Y; Liu D; Cheng Y; Zhou J; Cao Y
PLoS One; 2014; 9(4):e94252. PubMed ID: 24710115
[TBL] [Abstract][Full Text] [Related]
5. Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer.
Elhossary M; Hawash N; Badawi R; Yousef M; Abd-Elsalam S; Elhendawy M; Wasfy R; Abou-Saif S; ElBendary A; Ismail S
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):302-312. PubMed ID: 31241019
[TBL] [Abstract][Full Text] [Related]
6. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45.
Lim DH; Lee JH; Kim JW
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28186354
[TBL] [Abstract][Full Text] [Related]
8. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
9. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.
De Chiara L; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Cordero OJ; Martínez-Ares D; Páez de la Cadena M
BMC Cancer; 2010 Jun; 10():333. PubMed ID: 20584285
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer.
Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
12. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
[TBL] [Abstract][Full Text] [Related]
13. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.
Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM
Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting.
Werner S; Krause F; Rolny V; Strobl M; Morgenstern D; Datz C; Chen H; Brenner H
Clin Cancer Res; 2016 Apr; 22(7):1725-33. PubMed ID: 26561557
[TBL] [Abstract][Full Text] [Related]
17. Increased MACC1 levels in tissues and blood identify colon adenoma patients at high risk.
Ashktorab H; Hermann P; Nouraie M; Shokrani B; Lee E; Haidary T; Brim H; Stein U
J Transl Med; 2016 Jul; 14(1):215. PubMed ID: 27439755
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.
Mead R; Duku M; Bhandari P; Cree IA
Br J Cancer; 2011 Jul; 105(2):239-45. PubMed ID: 21712823
[TBL] [Abstract][Full Text] [Related]
19. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
[TBL] [Abstract][Full Text] [Related]
20. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
